{"id":12529,"date":"2025-12-15T23:47:55","date_gmt":"2025-12-15T21:47:55","guid":{"rendered":"https:\/\/stemlix.com\/?p=12529"},"modified":"2025-12-15T23:47:55","modified_gmt":"2025-12-15T21:47:55","slug":"allogeneic-hematopoietic-stem-cell-transplant","status":"publish","type":"post","link":"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/","title":{"rendered":"allogeneic hematopoietic stem cell transplant"},"content":{"rendered":"<div class=\"markdown prose dark:prose-invert w-full break-words light markdown-new-styling\"><p data-start=\"0\" data-end=\"84\"><strong data-start=\"0\" data-end=\"84\">Allogeneic Hematopoietic Stem Cell Transplant: Overview, Procedure, and Benefits<\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">\u0645\u062d\u062a\u0648\u064a\u0627\u062a \u0627\u0644\u0635\u0641\u062d\u0629<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#What_is_Allogeneic_Hematopoietic_Stem_Cell_Transplant\" >What is Allogeneic Hematopoietic Stem Cell Transplant?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#How_Does_Allogeneic_HSCT_Work\" >How Does Allogeneic HSCT Work?<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#1_Pre-transplant_Conditioning_Chemotherapy_or_Radiation\" >1. Pre-transplant Conditioning (Chemotherapy or Radiation)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#2_Stem_Cell_Collection\" >2. Stem Cell Collection<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#3_Infusion_of_Stem_Cells\" >3. Infusion of Stem Cells<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#4_Post-transplant_Care_and_Monitoring\" >4. Post-transplant Care and Monitoring<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#Types_of_Donors_for_Allogeneic_HSCT\" >Types of Donors for Allogeneic HSCT<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#Benefits_of_Allogeneic_HSCT\" >Benefits of Allogeneic HSCT<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#Risks_and_Complications\" >Risks and Complications<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#Success_Rates\" >Success Rates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#Frequently_Asked_Questions_FAQs\" >Frequently Asked Questions (FAQs)<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#1_What_is_the_difference_between_allogeneic_and_autologous_stem_cell_transplants\" >1. What is the difference between allogeneic and autologous stem cell transplants?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#2_How_long_does_it_take_to_recover_from_an_allogeneic_HSCT\" >2. How long does it take to recover from an allogeneic HSCT?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#3_Can_the_stem_cell_transplant_cure_blood_cancers\" >3. Can the stem cell transplant cure blood cancers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#4_What_are_the_risks_of_graft-versus-host_disease_GVHD\" >4. What are the risks of graft-versus-host disease (GVHD)?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/stemlix.com\/en\/allogeneic-hematopoietic-stem-cell-transplant\/#5_How_do_doctors_determine_if_a_patient_is_eligible_for_an_allogeneic_stem_cell_transplant\" >5. How do doctors determine if a patient is eligible for an allogeneic stem cell transplant?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h3 data-start=\"86\" data-end=\"144\"><span class=\"ez-toc-section\" id=\"What_is_Allogeneic_Hematopoietic_Stem_Cell_Transplant\"><\/span>What is Allogeneic Hematopoietic Stem Cell Transplant?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p data-start=\"146\" data-end=\"631\">An <strong data-start=\"149\" data-end=\"205\">allogeneic hematopoietic stem cell transplant (HSCT)<\/strong> is a medical procedure used to treat various types of blood cancers, such as leukemia, lymphoma, and multiple myeloma, as well as non-cancerous blood disorders like sickle cell anemia and severe aplastic anemia. This transplant involves transferring hematopoietic stem cells (the cells that form blood cells) from a donor to a patient. The donor can be a family member, an unrelated person, or even a partially matched donor.<\/p>\n<p data-start=\"633\" data-end=\"822\">The term &#8220;allogeneic&#8221; refers to the source of the stem cells: they come from a donor, as opposed to &#8220;autologous&#8221; transplants, where the stem cells are harvested from the patient themselves.<\/p>\n<h3 data-start=\"824\" data-end=\"858\"><span class=\"ez-toc-section\" id=\"How_Does_Allogeneic_HSCT_Work\"><\/span>How Does Allogeneic HSCT Work?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p data-start=\"860\" data-end=\"1139\">The goal of the transplant is to replace the patient&#8217;s diseased or damaged bone marrow with healthy stem cells. These stem cells are capable of producing new blood cells (red blood cells, white blood cells, and platelets), which can help the patient recover from their condition.<\/p>\n<p data-start=\"1141\" data-end=\"1183\">The process consists of several key steps:<\/p>\n<h4 data-start=\"1185\" data-end=\"1252\"><span class=\"ez-toc-section\" id=\"1_Pre-transplant_Conditioning_Chemotherapy_or_Radiation\"><\/span>1. <strong data-start=\"1193\" data-end=\"1252\">Pre-transplant Conditioning (Chemotherapy or Radiation)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p data-start=\"1256\" data-end=\"1434\">Before receiving the transplant, the patient undergoes a <strong data-start=\"1313\" data-end=\"1337\">conditioning regimen<\/strong>. This may involve chemotherapy, radiation, or a combination of both. The aim of this step is to:<\/p>\n<ul data-start=\"1438\" data-end=\"1557\">\n<li data-start=\"1438\" data-end=\"1482\">\n<p data-start=\"1440\" data-end=\"1482\">Destroy the patient&#8217;s diseased bone marrow<\/p>\n<\/li>\n<li data-start=\"1486\" data-end=\"1557\">\n<p data-start=\"1488\" data-end=\"1557\">Suppress the immune system to prevent rejection of the new stem cells<\/p>\n<\/li>\n<\/ul>\n<h4 data-start=\"1559\" data-end=\"1591\"><span class=\"ez-toc-section\" id=\"2_Stem_Cell_Collection\"><\/span>2. <strong data-start=\"1567\" data-end=\"1591\">Stem Cell Collection<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p data-start=\"1595\" data-end=\"1673\">The donor&#8217;s hematopoietic stem cells are collected through one of two methods:<\/p>\n<ul data-start=\"1677\" data-end=\"1999\">\n<li data-start=\"1677\" data-end=\"1792\">\n<p data-start=\"1679\" data-end=\"1792\"><strong data-start=\"1679\" data-end=\"1702\">Bone marrow harvest<\/strong>: Stem cells are collected directly from the donor\u2019s bone marrow under general anesthesia.<\/p>\n<\/li>\n<li data-start=\"1796\" data-end=\"1999\">\n<p data-start=\"1798\" data-end=\"1999\"><strong data-start=\"1798\" data-end=\"1851\">Peripheral blood stem cell collection (apheresis)<\/strong>: Stem cells are collected from the donor&#8217;s bloodstream after the donor is given growth factors to increase the number of stem cells in circulation.<\/p>\n<\/li>\n<\/ul>\n<h4 data-start=\"2001\" data-end=\"2035\"><span class=\"ez-toc-section\" id=\"3_Infusion_of_Stem_Cells\"><\/span>3. <strong data-start=\"2009\" data-end=\"2035\">Infusion of Stem Cells<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p data-start=\"2039\" data-end=\"2270\">The collected stem cells are infused into the patient\u2019s bloodstream through an IV line. This process is similar to a blood transfusion. The stem cells travel to the bone marrow, where they begin to produce new, healthy blood cells.<\/p>\n<h4 data-start=\"2272\" data-end=\"2319\"><span class=\"ez-toc-section\" id=\"4_Post-transplant_Care_and_Monitoring\"><\/span>4. <strong data-start=\"2280\" data-end=\"2319\">Post-transplant Care and Monitoring<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p data-start=\"2323\" data-end=\"2541\">After the transplant, the patient undergoes close monitoring for any complications. The new stem cells will gradually begin to take over the production of blood cells, but this process can take several weeks to months.<\/p>\n<h3 data-start=\"2543\" data-end=\"2582\"><span class=\"ez-toc-section\" id=\"Types_of_Donors_for_Allogeneic_HSCT\"><\/span>Types of Donors for Allogeneic HSCT<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p data-start=\"2584\" data-end=\"2767\">The success of an allogeneic hematopoietic stem cell transplant depends heavily on the compatibility between the donor&#8217;s and recipient&#8217;s tissues. There are three main types of donors:<\/p>\n<ol data-start=\"2769\" data-end=\"3190\">\n<li data-start=\"2769\" data-end=\"2893\">\n<p data-start=\"2772\" data-end=\"2893\"><strong data-start=\"2772\" data-end=\"2797\">Matched Sibling Donor<\/strong>: A brother or sister who has the same human leukocyte antigen (HLA) tissue type as the patient.<\/p>\n<\/li>\n<li data-start=\"2894\" data-end=\"3073\">\n<p data-start=\"2897\" data-end=\"3073\"><strong data-start=\"2897\" data-end=\"2916\">Unrelated Donor<\/strong>: An individual who is not a family member but has a matching HLA type. This type of donor is often found through national or international donor registries.<\/p>\n<\/li>\n<li data-start=\"3074\" data-end=\"3190\">\n<p data-start=\"3077\" data-end=\"3190\"><strong data-start=\"3077\" data-end=\"3097\">Mismatched Donor<\/strong>: In some cases, a donor who is not an exact match but has partial compatibility may be used.<\/p>\n<\/li>\n<\/ol>\n<h3 data-start=\"3192\" data-end=\"3223\"><span class=\"ez-toc-section\" id=\"Benefits_of_Allogeneic_HSCT\"><\/span>Benefits of Allogeneic HSCT<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p data-start=\"3225\" data-end=\"3371\">Allogeneic HSCT offers significant potential benefits for patients, especially those with blood cancers or certain blood disorders. These include:<\/p>\n<ul data-start=\"3373\" data-end=\"3868\">\n<li data-start=\"3373\" data-end=\"3532\">\n<p data-start=\"3375\" data-end=\"3532\"><strong data-start=\"3375\" data-end=\"3401\">Curing Blood Disorders<\/strong>: For many patients with leukemia, lymphoma, and other blood cancers, this transplant is one of the few curative treatment options.<\/p>\n<\/li>\n<li data-start=\"3533\" data-end=\"3694\">\n<p data-start=\"3535\" data-end=\"3694\"><strong data-start=\"3535\" data-end=\"3569\">Improved Blood Cell Production<\/strong>: The new stem cells can restore normal blood cell production, helping to alleviate symptoms caused by low blood cell counts.<\/p>\n<\/li>\n<li data-start=\"3695\" data-end=\"3868\">\n<p data-start=\"3697\" data-end=\"3868\"><strong data-start=\"3697\" data-end=\"3739\">Potential for Graft-vs-Leukemia Effect<\/strong>: In some cases, the transplanted immune cells can help fight any remaining cancer cells, providing additional treatment benefit.<\/p>\n<\/li>\n<\/ul>\n<h3 data-start=\"3870\" data-end=\"3897\"><span class=\"ez-toc-section\" id=\"Risks_and_Complications\"><\/span>Risks and Complications<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p data-start=\"3899\" data-end=\"4010\">While allogeneic HSCT has the potential for life-saving benefits, it also carries significant risks, including:<\/p>\n<ul data-start=\"4012\" data-end=\"4521\">\n<li data-start=\"4012\" data-end=\"4181\">\n<p data-start=\"4014\" data-end=\"4181\"><strong data-start=\"4014\" data-end=\"4050\">Graft-Versus-Host Disease (GVHD)<\/strong>: This occurs when the donor&#8217;s immune cells attack the patient\u2019s body, leading to complications that can range from mild to severe.<\/p>\n<\/li>\n<li data-start=\"4182\" data-end=\"4315\">\n<p data-start=\"4184\" data-end=\"4315\"><strong data-start=\"4184\" data-end=\"4198\">Infections<\/strong>: The patient\u2019s immune system is weakened after the conditioning regimen, making them more susceptible to infections.<\/p>\n<\/li>\n<li data-start=\"4316\" data-end=\"4401\">\n<p data-start=\"4318\" data-end=\"4401\"><strong data-start=\"4318\" data-end=\"4331\">Rejection<\/strong>: Although rare, the patient\u2019s body might reject the donor stem cells.<\/p>\n<\/li>\n<li data-start=\"4402\" data-end=\"4521\">\n<p data-start=\"4404\" data-end=\"4521\"><strong data-start=\"4404\" data-end=\"4420\">Organ Damage<\/strong>: Chemotherapy, radiation, and GVHD can cause damage to organs such as the liver, lungs, and kidneys.<\/p>\n<\/li>\n<\/ul>\n<h3 data-start=\"4523\" data-end=\"4540\"><span class=\"ez-toc-section\" id=\"Success_Rates\"><\/span>Success Rates<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p data-start=\"4542\" data-end=\"4949\">The success of allogeneic HSCT depends on various factors, including the patient\u2019s age, overall health, the type of disease being treated, and how well the donor and recipient are matched. Typically, younger patients with good overall health and a well-matched donor have better outcomes. However, advancements in supportive care and immune-modulating therapies have improved survival rates in recent years.<\/p>\n<h3 data-start=\"4951\" data-end=\"4988\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_FAQs\"><\/span>Frequently Asked Questions (FAQs)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<h4 data-start=\"4990\" data-end=\"5081\"><span class=\"ez-toc-section\" id=\"1_What_is_the_difference_between_allogeneic_and_autologous_stem_cell_transplants\"><\/span>1. <strong data-start=\"4998\" data-end=\"5081\">What is the difference between allogeneic and autologous stem cell transplants?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p data-start=\"5085\" data-end=\"5277\">In an allogeneic transplant, the stem cells come from a donor, while in an autologous transplant, the stem cells are collected from the patient themselves before treatment and then re-infused.<\/p>\n<h4 data-start=\"5279\" data-end=\"5348\"><span class=\"ez-toc-section\" id=\"2_How_long_does_it_take_to_recover_from_an_allogeneic_HSCT\"><\/span>2. <strong data-start=\"5287\" data-end=\"5348\">How long does it take to recover from an allogeneic HSCT?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p data-start=\"5352\" data-end=\"5517\">Recovery can take several months to a year, depending on the patient\u2019s response to the transplant, the occurrence of complications, and the patient\u2019s overall health.<\/p>\n<h4 data-start=\"5519\" data-end=\"5579\"><span class=\"ez-toc-section\" id=\"3_Can_the_stem_cell_transplant_cure_blood_cancers\"><\/span>3. <strong data-start=\"5527\" data-end=\"5579\">Can the stem cell transplant cure blood cancers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p data-start=\"5583\" data-end=\"5725\">Yes, for many patients, an allogeneic HSCT can provide a potential cure, especially for those with leukemia or other aggressive blood cancers.<\/p>\n<h4 data-start=\"5727\" data-end=\"5794\"><span class=\"ez-toc-section\" id=\"4_What_are_the_risks_of_graft-versus-host_disease_GVHD\"><\/span>4. <strong data-start=\"5735\" data-end=\"5794\">What are the risks of graft-versus-host disease (GVHD)?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p data-start=\"5798\" data-end=\"6024\">GVHD is a serious risk, particularly in allogeneic transplants, where the donor\u2019s immune cells may attack the recipient\u2019s tissues. The severity ranges from mild to severe, and management involves immune-suppressing treatments.<\/p>\n<h4 data-start=\"6026\" data-end=\"6127\"><span class=\"ez-toc-section\" id=\"5_How_do_doctors_determine_if_a_patient_is_eligible_for_an_allogeneic_stem_cell_transplant\"><\/span>5. <strong data-start=\"6034\" data-end=\"6127\">How do doctors determine if a patient is eligible for an allogeneic stem cell transplant?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p data-start=\"6131\" data-end=\"6276\">Eligibility depends on factors such as the type and stage of the disease, the patient&#8217;s overall health, and the availability of a suitable donor.<\/p>\n<p data-start=\"6278\" data-end=\"6559\" data-is-last-node=\"\" data-is-only-node=\"\">Allogeneic hematopoietic stem cell transplant is a complex procedure but can offer a lifeline for patients with certain cancers or blood disorders. Though the treatment carries risks, it also holds the potential for significant benefits, including remission and long-term survival.<\/p><\/div>","protected":false},"excerpt":{"rendered":"<p>Allogeneic Hematopoietic Stem Cell Transplant: Overview, Procedure, and Benefits What is Allogeneic Hematopoietic Stem Cell Transplant? An allogeneic hematopoietic stem cell transplant (HSCT) is a medical procedure used to treat various types of blood cancers, such as leukemia, lymphoma, and multiple myeloma, as well as non-cancerous blood disorders like sickle cell anemia and severe aplastic&#8230;<\/p>","protected":false},"author":11,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[],"class_list":["post-12529","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/posts\/12529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/comments?post=12529"}],"version-history":[{"count":1,"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/posts\/12529\/revisions"}],"predecessor-version":[{"id":12770,"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/posts\/12529\/revisions\/12770"}],"wp:attachment":[{"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/media?parent=12529"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/categories?post=12529"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stemlix.com\/en\/wp-json\/wp\/v2\/tags?post=12529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}